Vimarsana
Biggest News Aggregation in the World

Page 6 - Nt Ears News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nt Ears. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nt Ears Today - Breaking & Trending Today

AI 'Sees' When Patients Are in Pain - Vimarsana News

AI 'Sees' When Patients Are in Pain

Facial expressions could be interpreted by computers as a biomarker of pain, research suggests.

FDA Approves New Drug for Ulcerative Colitis - Vimarsana News

FDA Approves New Drug for Ulcerative Colitis

Mirikizumab (Omvoh) is the first IL-23 inhibitor to be approved in the United States for the treament of moderately to severely active ulcerative colitis.

Dupilumab Promising for Children Up to 12 Years Old With EoE - Vimarsana News

Dupilumab Promising for Children Up to 12 Years Old With EoE

New evidence supports the safety and efficacy of dupilumab for children aged 1-11 years with eosinophilic esophagitis.

Trilogy TAVR Safe, Effective in Aortic Regurgitation - Vimarsana News

Trilogy TAVR Safe, Effective in Aortic Regurgitation

The Trilogy transcatheter aortic valve replacement system was safe and effective for high-risk surgical patients with aortic regurgitation, improving LV remodeling and function, in the ALIGN-AR trial.

FDA Approves Subcutaneous Infliximab for IBD - Vimarsana News

FDA Approves Subcutaneous Infliximab for IBD

The approval provides an alternative administration option for delivering the drug to patients with moderately to severely active ulcerative colitis or Crohn's disease.